Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chelsea C Pinnix

Showing results (1-10 of 159) with videos related to

Pageof 16
Sort By:
The Lancet. Haematology|February 1, 2021
A call for an unbalanced force to combat racism and health disparityChelsea C Pinnix
International Journal of Radiation Oncology, Biology, Physics|March 15, 2016
Radiation Therapy for Diffuse Large B-Cell Lymphoma: Indications, Outcomes, and ControversiesChelsea C Pinnix
Pigment Cell Research|October 16, 2007
The many faces of Notch signaling in skin-derived cellsChelsea C Pinnix, Meenhard Herlyn
JAMA Oncology|December 16, 2016
Lymphoma and Pregnancy-ReplyChelsea C Pinnix, Michelle A Fanale
The Lancet. Haematology|June 27, 2024
Measurable residual disease-driven therapy after radiotherapy for early-stage follicular lymphomaJillian R Gunther, Chelsea C Pinnix
JAMA Oncology|October 23, 2018
Avoiding Topical Agents Before Daily Radiotherapy: Debunking DogmaSimon A Brown, Chelsea C Pinnix
International Journal of Radiation Oncology, Biology, Physics|November 18, 2021
Chemoradiation to Improve Local Control, and Thereby Overall Survival for Limited Stage Nasal NKTCLSusan Y Wu, Chelsea C Pinnix
Journal of the National Comprehensive Cancer Network : JNCCN|July 10, 2012
Gastric MALT lymphoma treated with primary radiotherapy in the setting of autoimmune diseaseChelsea C Pinnix, Valerie Reed, Bouthaina Dabaja
The British Journal of Radiology|August 11, 2021
Salvage radiotherapy for primary refractory and relapsed diffuse large B-Cell lymphomaEric D Brooks, Penny Fang, Chelsea C Pinnix
International Journal of Radiation Oncology, Biology, Physics|April 25, 2019
Immune Therapies for Lymphomas: A Disruptive Technology With Opportunities for RadiationMichael J LaRiviere, Chelsea C Pinnix, John P Plastaras
Pageof 16

Showing results (1-10 of 159) with videos related to

Sort By:
Pageof 16
The Lancet. Haematology|February 1, 2021
A call for an unbalanced force to combat racism and health disparityChelsea C Pinnix
International Journal of Radiation Oncology, Biology, Physics|March 15, 2016
Radiation Therapy for Diffuse Large B-Cell Lymphoma: Indications, Outcomes, and ControversiesChelsea C Pinnix
Pigment Cell Research|October 16, 2007
The many faces of Notch signaling in skin-derived cellsChelsea C Pinnix, Meenhard Herlyn
JAMA Oncology|December 16, 2016
Lymphoma and Pregnancy-ReplyChelsea C Pinnix, Michelle A Fanale
The Lancet. Haematology|June 27, 2024
Measurable residual disease-driven therapy after radiotherapy for early-stage follicular lymphomaJillian R Gunther, Chelsea C Pinnix
JAMA Oncology|October 23, 2018
Avoiding Topical Agents Before Daily Radiotherapy: Debunking DogmaSimon A Brown, Chelsea C Pinnix
International Journal of Radiation Oncology, Biology, Physics|November 18, 2021
Chemoradiation to Improve Local Control, and Thereby Overall Survival for Limited Stage Nasal NKTCLSusan Y Wu, Chelsea C Pinnix
Journal of the National Comprehensive Cancer Network : JNCCN|July 10, 2012
Gastric MALT lymphoma treated with primary radiotherapy in the setting of autoimmune diseaseChelsea C Pinnix, Valerie Reed, Bouthaina Dabaja
The British Journal of Radiology|August 11, 2021
Salvage radiotherapy for primary refractory and relapsed diffuse large B-Cell lymphomaEric D Brooks, Penny Fang, Chelsea C Pinnix
International Journal of Radiation Oncology, Biology, Physics|April 25, 2019
Immune Therapies for Lymphomas: A Disruptive Technology With Opportunities for RadiationMichael J LaRiviere, Chelsea C Pinnix, John P Plastaras
Pageof 16